Inability to Walk, Disequilibrium, Incoherent Speech, Disorientation Following the Instillation of 1% Cyclopentolate Eyedrops
Cyclopentolate
Disequilibrium
Cycloplegia
Scopolamine
DOI:
10.1097/pec.0b013e3182417a63
Publication Date:
2012-01-06T00:42:26Z
AUTHORS (2)
ABSTRACT
A 4-year-old boy, who had no prior history of convulsions, presented with inability to walk, disequilibrium, dysarthria (incoherent speech), and impaired cognition (disorientation) following the instillation 1% cyclopentolate, a commonly used mydriatic in pediatric practice. This case demonstrates uncommon, although serious, atropine-like adverse effect cyclopentolate eyedrops usual dosage child.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (7)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....